Matej Oresic
banner
matejoresic.bsky.social
Matej Oresic
@matejoresic.bsky.social
Metabolomics, exposomics, systems medicine, health.
Publications: https://scholar.google.com/citations?user=9044ZHIAAAAJ&hl=en
Professor of Medicine (Systems medicine) at Örebro University 🇸🇪 & Professor of Biochemistry (Metabolomics) at Turku University 🇫🇮.
Reposted by Matej Oresic
🏆EMN Travel Awards are back for #MetSoc2025 in Prague!

EMN Travel Award – Up to 4 grants for graduate (Master’s/PhD) & postdocs.

📍More info: metabolomics2025.org/awards

#Metabolomics #EMN
February 7, 2025 at 6:11 AM
New review from our team:
Liquid and gas-chromatography-mass spectrometry methods for #exposome analysis
doi.org/10.1016/j.ch...
Redirecting
doi.org
February 2, 2025 at 11:27 AM
Video recording from yesterday #LipidMet (#Lipidomics task group of the #Metabolomics Soc) meeting is already available, alongside with records from prior meetings:
seafile.utu.fi/d/7b0a44f940...
Next LipidMet meeting will be on Monday March 24 at noon UTC. Agenda TBA.
January 28, 2025 at 10:10 AM
Excited to be part of STEP (#CBD in #psychosis) trials highlighted on the list of 11 trials to watch in 2025 by Nature Medicine
rdcu.be/d4b9O
as leader of peripheral #biomarkers WP, and also doing #metabolomics / #lipidomics / #endocannabinoids etc.
Finally starting in 2025
#proteomics #multiomics
Eleven clinical trials that will shape medicine in 2025
Nature Medicine - Nature Medicine asks leading researchers to name their top clinical trial for 2025, from gene therapies for prion disease and sickle-cell disease to digital tools for cancer and...
rdcu.be
December 19, 2024 at 5:29 PM
Deadline extended to January 7th.
New #postdoc / senior researcher position in our team at Turku #Metabolomics Centre (@BioscienceTurku / @UniTurku), in #massspectrometry #imaging.
#MSimaging #lipidomics #proteomics
December 18, 2024 at 10:07 AM
New paper, collaboration with Amalia Gastaldelli lab. Excellent work by Silvia Sabatini!
Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis:
www.cell.com/cell-reports...
#MASH #T2D #insulinresistance #GSMM
Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis
Sabatini et al. demonstrate that glucose production is enhanced in individuals with MASH and is associated with hepatic fibrosis and inflammation. These findings reveal altered hepatic glucose metabol...
www.cell.com
November 21, 2024 at 3:14 PM